Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

(2014) Nishant Agrawal et al.   CELL

Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines

(2014) Mika Shimamura et al.   ENDOCRINE JOURNAL

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

(2014) Miguel Melo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

(2013) Xiaoli Liu et al.   ENDOCRINE-RELATED CANCER

Diagnostic and prognostic implications of thePAX8-PPARγtranslocation in thyroid carcinomas-a TMA-based study of 226 cases

(2013) Laura A Boos et al.   HISTOPATHOLOGY

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

(2013) Mingzhao Xing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Frequent SomaticTERTPromoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease

(2013) Iñigo Landa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma

(2013) Toni Beninato et al.   SURGERY

Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma

(2012) Oskar Koperek et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Poorly differentiated oncocytic thyroid carcinoma - diagnostic implications and outcome

(2012) Matthias Dettmer et al.   HISTOPATHOLOGY

A High Percentage ofBRAFV600EAlleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome

(2012) Anna Guerra et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas

(2012) Valentina Sancisi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

TheBRAFV600EMutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study

(2012) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BRAFV600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis

(2012) Carol Li et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Poorly Differentiated Thyroid Carcinomas

(2011) Matthias Dettmer et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

(2011) Tae Hyuk Kim et al.   CANCER

The Primary Occurrence ofBRAFV600EIs a Rare Clonal Event in Papillary Thyroid Carcinoma

(2011) Anna Guerra et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases

(2011) Catarina Eloy et al.   VIRCHOWS ARCHIV

Papillary Carcinoma Tall Cell Variant (TCV): A Review

(2010) Virginia A. LiVolsi   ENDOCRINE PATHOLOGY

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

(2010) Daria Handkiewicz-Junak et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

(2010) Shinichi Yachida et al.   NATURE

BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients

(2009) Yasuhiro ITO et al.   ENDOCRINE JOURNAL

Papillary Thyroid Carcinoma Tall Cell Variant

(2008) Ronald Ghossein et al.   THYROID